{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:35Z","timestamp":1787019575738,"version":"build-2736575974"},"reference-count":41,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>At our center, we observed a series of patients who developed transudative refractory ascites secondary to noncirrhotic, non-veno-occlusive disease (VOD)\u2013related portal hypertension after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Patients were considered to have idiopathic portal hypertension-related refractory ascites (IRA) if they developed ascites secondary to intrahepatic portal hypertension (serum ascites albumin gradient \u22651.1 g\/dL or hepatic venous pressure gradient [HVPG] &amp;gt;5 mm Hg), but did not meet the clinical criteria for classical VOD\/sinusoidal obstructive syndrome (SOS) and did not have any alternate etiology of portal hypertension. From our institutional database, we identified 40 patients who developed IRA after allo-HSCT between 2004 and 2018. The patients\u2019 median age at the time of allo-HSCT was 54 years (range, 21-73 years). The median time to development of IRA after allo-HSCT was 80 days (range, 16-576 days). The median number of paracentesis was 3 (range, 1-11), and 15 (38%) patients had an intraperitoneal catheter placed for continued drainage of the rapidly accumulating ascites. Portal pressures were measured in 19 patients; 6 (15%) had moderate portal hypertension (HVPG 6-9 mm Hg), and 13 (33%) had severe portal hypertension (HVPG \u2265 10 mm Hg). Liver biopsy was performed in 24 patients. None of the patients met the criteria for classical VOD\/SOS (clinical\/histological) or cirrhosis (histological). The cumulative incidence of nonrelapse mortality was 63%, and the median survival duration after the development of the IRA was 7 months (range, 0.8-125.6 months). IRA is a poorly understood and often fatal complication of allo-HSCT.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000638","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T11:37:59Z","timestamp":1585741079000},"page":"1296-1306","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-9451","authenticated-orcid":false,"given":"Ankur","family":"Varma","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"},{"name":"Division of Hematology, Oncology and Cellular Therapy, Rush University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Abraham","sequence":"first","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohtesh S.","family":"Mehta","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj Y.","family":"Saini","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhavi","family":"Honhar","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Comer Children's Hospital, Chicago, IL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4743-1620","authenticated-orcid":false,"given":"Munazza","family":"Rashid","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer A.","family":"Srour","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4086-6453","authenticated-orcid":false,"given":"Qaiser","family":"Bashir","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Rondon","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Oran","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra M.","family":"Hosing","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6034-8939","authenticated-orcid":false,"given":"Yago","family":"Nieto","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partow","family":"Kebriaei","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin M.","family":"Alousi","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-8299","authenticated-orcid":false,"given":"Sairah","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Marin","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa F.","family":"Khouri","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan O.","family":"Ciurea","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar H.","family":"Qazilbash","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Rezvani","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Anderlini","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borje S.","family":"Andersson","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-5037","authenticated-orcid":false,"given":"Richard E.","family":"Champlin","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-2224","authenticated-orcid":false,"given":"Uday R.","family":"Popat","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"issue":"6","key":"2020041411282593100_B1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/gut.23.6.465","article-title":"Liver disease after bone marrow transplantation","volume":"23","author":"Farthing","year":"1982","journal-title":"Gut"},{"issue":"10","key":"2020041411282593100_B2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1470-2045(12)70349-2","article-title":"Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial","volume":"13","author":"Bornh\u00e4user","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"2020041411282593100_B3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2003-04-1311","article-title":"Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients","volume":"103","author":"Hogan","year":"2004","journal-title":"Blood"},{"issue":"10","key":"2020041411282593100_B4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bmt.1703697","article-title":"Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience","volume":"30","author":"Basara","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2020041411282593100_B5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"issue":"4","key":"2020041411282593100_B6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol Int"},{"key":"2020041411282593100_B7","volume-title":"Pathophysiology of Disease: An Introduction to Clinical Medicine, 7th ed","author":"Khalili","year":"2013"},{"issue":"10","key":"2020041411282593100_B8","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2020041411282593100_B9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"issue":"4","key":"2020041411282593100_B10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"issue":"10","key":"2020041411282593100_B11","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","article-title":"Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan\/cyclophosphamide","volume":"79","author":"Essell","year":"1992","journal-title":"Blood"},{"issue":"2","key":"2020041411282593100_B12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020041411282593100_B13","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"issue":"11","key":"2020041411282593100_B14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"2020041411282593100_B15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12288-014-0477-y","article-title":"Ascites as a manifestation of GVHD: a rare phenomenon","volume":"32","author":"Bagal","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"7","key":"2020041411282593100_B16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2020041411282593100_B17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"issue":"1","key":"2020041411282593100_B18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000084723","article-title":"Refractory ascites","volume":"23","author":"C\u00e1rdenas","year":"2005","journal-title":"Dig Dis"},{"issue":"8","key":"2020041411282593100_B19","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3109\/10428194.2012.661052","article-title":"Clinicopathologic features of late-onset veno-occlusive disease\/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant","volume":"53","author":"Pai","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2020041411282593100_B20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","article-title":"Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation","volume":"24","author":"Toh","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2020041411282593100_B21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.bbmt.2007.08.002","article-title":"Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients","volume":"13","author":"Carreras","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2020041411282593100_B22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bmt.1704242","article-title":"Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL","volume":"32","author":"Ivanov","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020041411282593100_B23","first-page":"207","article-title":"Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease","volume":"17","author":"Seber","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020041411282593100_B24","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.4081\/hr.2016.6482","article-title":"Refractory ascites with liver fibrosis developed in late phase allogeneic hematopoietic stem cell transplantation: report of three patients","volume":"8","author":"Hosoi","year":"2016","journal-title":"Hematol Rep"},{"issue":"5","key":"2020041411282593100_B25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1083-8791(99)70006-6","article-title":"Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome","volume":"5","author":"Lee","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2020041411282593100_B26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"2020041411282593100_B27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5858\/arpa.2015-0388-OA","article-title":"The spectrum of histologic findings in hepatic outflow obstruction","volume":"141","author":"Gonzalez","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"13","key":"2020041411282593100_B28","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3748\/wjg.v13.i13.1912","article-title":"Hepatic venous outflow obstruction: three similar syndromes","volume":"13","author":"Bayraktar","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2020041411282593100_B29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00428-018-2355-8","article-title":"Pathology of idiopathic non-cirrhotic portal hypertension","volume":"473","author":"Guido","year":"2018","journal-title":"Virchows Arch"},{"issue":"12","key":"2020041411282593100_B30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00277-012-1541-z","article-title":"Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"issue":"8","key":"2020041411282593100_B31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/bmt.2015.105","article-title":"Chronic GvHD-associated serositis and pericarditis","volume":"50","author":"Leonard","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2020041411282593100_B32","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1002\/ajh.24435","article-title":"Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Modi","year":"2016","journal-title":"Am J Hematol"},{"issue":"4","key":"2020041411282593100_B33","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"issue":"25","key":"2020041411282593100_B34","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3748\/wjg.15.3128","article-title":"Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases","volume":"15","author":"Abu-Hilal","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2020041411282593100_B35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.1840170214","article-title":"Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations","volume":"17","author":"Dubois","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"2020041411282593100_B36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1440-1746.2002.02764.x","article-title":"Non-cirrhotic portal fibrosis: current concepts and management","volume":"17","author":"Sarin","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"2020041411282593100_B37","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"2020041411282593100_B38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","article-title":"Non-cirrhotic portal hypertension - diagnosis and management","volume":"60","author":"Khanna","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"2020041411282593100_B39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"issue":"3","key":"2020041411282593100_B40","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"issue":"10","key":"2020041411282593100_B41","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V93.10.3259.410k13_3259_3266","article-title":"Cirrhosis of the liver in long-term marrow transplant survivors","volume":"93","author":"Strasser","year":"1999","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/7\/1296\/1724311\/advancesadv2019000638.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/7\/1296\/1724311\/advancesadv2019000638.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T11:29:59Z","timestamp":1586863799000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/7\/1296\/454185\/Idiopathic-refractory-ascites-after-allogeneic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000638","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}